Scarica l'app Stockscreener
0.797
6.24%
-0.053
Dopo l'orario di chiusura:
.80
0.003
+0.38%
Precedente Chiudi:
$0.85
Aprire:
$0.9
Volume 24 ore:
16.21M
Relative Volume:
3.52
Capitalizzazione di mercato:
$132.71M
Reddito:
-
Utile/perdita netta:
$-111.13M
Rapporto P/E:
-0.6038
EPS:
-1.32
Flusso di cassa netto:
$-91.53M
1 W Prestazione:
-42.66%
1M Prestazione:
-40.08%
6M Prestazione:
+34.74%
1 anno Prestazione:
-71.02%
Intervallo 1D:
$0.79
$0.904
Intervallo di 1 settimana:
$0.785
$1.46
Portata 52W:
$0.36
$2.92
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
Tenaya Therapeutics Inc
Settore
Industria
Telefono
415-865-2066
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.797 | 141.53M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform |
| 2023-11-30 | Iniziato | Leerink Partners | Outperform |
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Wilson Sonsini Advises Tenaya Therapeutics on Pricing of Public Offering - Wilson Sonsini
Tenaya fundraising follows resolution of clinical hold - The Pharma Letter
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data - Investing.com India
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M FundraiseWhat's Changed - Yahoo Finance
Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright - MarketBeat
Chardan Capital Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $8.00 - MarketBeat
Chardan Capital Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
Pharma News: Will Tenaya Therapeutics Inc stock remain a Wall Street favorite2025 Market Sentiment & Weekly Return Optimization Plans - moha.gov.vn
Tenaya Stock Drops After Announcing $60M Equity OfferingTenaya Therapeutics (NASDAQ:TNYA) - Benzinga
Tenaya Therapeutics (TNYA) Price Target Lowered by HC Wainwright & Co. | TNYA Stock News - GuruFocus
Tenaya Therapeutics slumps after $60 million share sale - TradingView — Track All Markets
Tenaya Therapeutics Prices 50 Mln Unit Offering At $60 Mln, Clinical Hold Lifted On TN-201 - Nasdaq
Tenaya Therapeutics announces positive data from Phase 1b/2 trial - Traders Union
TNYA: Chardan Capital Lowers Price Target While Maintaining Buy Rating | TNYA Stock News - GuruFocus
Tenaya Therapeutics Prices $60 Million Unit Offering - marketscreener.com
Tenaya Therapeutics prices $60 million public offering of stock and warrants - Investing.com Nigeria
Tenaya Therapeutics Announces Pricing of Public Offering - The Manila Times
Tenaya Therapeutics Announces Pricing of Public Offering | Associated Press | syndication news - Enidnews.com
Tenaya Therapeutics (TNYA) prices $60M public unit sale of 50,000,000 units - Stock Titan
Tenaya Therapeutics Says FDA Hold Removed on TN-201, Posts Positive TN-401 Interim Data, Plans Stock, Warrant Offering - marketscreener.com
Tenaya Therapeutics slides after launching stock offering - TradingView — Track All Markets
Tenaya Therapeutics plans to offer stock and warrant units By Investing.com - Investing.com Canada
Tenaya Therapeutics plans to offer stock and warrant units - Investing.com
FDA lifts clinical hold on Tenaya’s heart disease gene therapy trial - Investing.com Nigeria
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy - Investing News Network
Tenaya Therapeutics stock falls on proposed share and warrant offering - Investing.com
Tenaya Therapeutics stock falls on proposed share and warrant offering By Investing.com - Investing.com UK
Tenaya Therapeutics says early trial shows promise for gene therapy in rare heart condition - marketscreener.com
Tenaya Therapeutics (Nasdaq: TNYA) proposes unit offering of common stock and warrants - Stock Titan
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical ... - Bakersfield.com
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC - The Manila Times
Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewswire
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Path To Profitability - simplywall.st
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Earnings Beat: Will Tenaya Therapeutics Inc. stock outperform growth indexesJuly 2025 Price Swings & AI Driven Stock Movement Reports - moha.gov.vn
Will Tenaya Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Why Tenaya Therapeutics Inc. stock is considered a top pick2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform - Seeking Alpha
Can Tenaya Therapeutics Inc. stock resist market sell offs2025 Top Gainers & High Conviction Investment Ideas - Newser
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Will Tenaya Therapeutics Inc. stock return to pre crisis levelsEarnings Overview Report & Safe Entry Point Identification - Newser
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga
Is Tenaya Therapeutics Inc. stock attractive for hedge fundsMarket Movers & Expert Approved Trade Ideas - BỘ NỘI VỤ
Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN
How geopolitical tensions affect Tenaya Therapeutics Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Will Tenaya Therapeutics (NASDAQ:TNYA) Spend Its Cash Wisely? - Yahoo Finance
How supply chain issues affect Tenaya Therapeutics Inc. stock - newser.com
How resilient is Tenaya Therapeutics Inc. stock in market downturnsIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):